Acadia Healthcare Affirms FY24 Adj. EPS $3.40-$3.70 Vs $3.54 Est.; Revenue $3.18B-$3.25B Vs $3.22B Est.
Portfolio Pulse from Benzinga Newsdesk
Acadia Healthcare has provided its financial outlook for FY24, projecting adjusted EPS in the range of $3.40 to $3.70, compared to the estimated $3.54. The company also forecasts revenue to be between $3.18 billion and $3.25 billion, aligning closely with the estimated $3.22 billion.
May 01, 2024 | 8:45 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Acadia Healthcare projects FY24 adjusted EPS of $3.40-$3.70, closely matching the $3.54 estimate, and anticipates revenues of $3.18B-$3.25B, nearly meeting the $3.22B estimate.
The financial outlook provided by Acadia Healthcare for FY24 shows a tight alignment with analyst estimates, indicating a stable financial performance. The EPS range slightly encompasses the estimated value, suggesting a cautious but optimistic outlook. The revenue forecast is also very close to the estimates, which could mean that the market has already anticipated this performance level. Given the close match with expectations, the short-term impact on ACHC's stock price is likely to be neutral, as the outlook confirms rather than exceeds market expectations.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100